CNDSN August 6th news] (Contemporary direct Kong Qingbao) Confucius the 73 generation successor, 1999 to 50000 yuan business, to create a today output value of billions of Shandong Yi Bao biotechnology group (including Shandong Yi Bao Biological Products Co., Ltd., Shandong Yibao Import & Export Trade Co., Ltd, Shandong Fusen Kang Biotechnology Co., Ltd., the United States Yi Bao Co., Ltd.) and served as chairman of the group.

After graduation, Kong Qingbao has been committed to the research and development of bio pharmaceutical industry, engaged in bio pharmaceutical raw materials for more than ten years, fully demonstrated its professional skills, rich experience in management, intelligent entrepreneurs. The chondroitin production transformation process research and development, raw material development, has made great achievements, in the industry have made outstanding contributions.

Also as Shandong Yi Bao Biological Products Co., Ltd. (hereinafter referred to as "Shandong Yi Bao), chairman of, he through their continuous efforts has been highly recognized by the government and the society, has won a number of honors, many times by the relevant departments and Industry Association awarded" enterprise management outstanding person "," the pharmaceutical industry excellent entrepreneur "title of honor, has also repeatedly won the" Jining City venture pacesetter "," Jining City model worker ".

Because Kong Qingbao during the period of University majoring in the field of biotechnology, after graduation, have the opportunity to study abroad and found chondroitin in mainland China also belong to the blank, returning, after weighing immediately put all of his possessions to established Shandong Yi Bao, did not think the enterprise is done big, obsessed with just want to nationalize the chondroitin, let the Chinese people with its own production of chondroitin.

When the first star dream seed, has now grown into a towering tree. After more than ten years of development, today's Shandong Yi Bao has become the largest, most professional chondroitin manufacturer.

Kong Qingbao said: "let the chondroitin spread the concept of health to the society make known to every family, is my motivation to promote Shandong Yi bao. Because my major told me that chondroitin sulfate is the most effective elements in human skeletal health, on osteoporosis, shares osteonecrosis of the femoral head, arthritis and other skeletal disease has obvious health care effect, and in lowering blood pressure, lowering blood lipid, neuronal repair this has unique curative effect. But in China, Chinese people still know little about of chondroitin sulfate. This is a piece of my heart. Therefore, I hope to the good product promotion out, lets the people know chondroitin, let people in need are used on chondroitin. "

Kong Qingbao products as the foundation of enterprise development, he believes that a good product to win the recognition of consumers. Kong Qingbao said: "in order to create a high-quality chondroitin sulfate products, beneficial treasure company will increase cooperative efforts with the various universities, research institutes, and enhance the strength of research and development of products, continue to introduce new has high-tech content of high-quality health care products, provide strong security products for the market dealers and consumers. "

Kong Qingbao said: in the group of services, the company will implement a district of a county, a shop planning, the company set up a company directly under the branch, to achieve full coverage of the market network, to provide a full range of services to dealers to promote the rapid development of the company's market performance."

Kong Qingbao believes that biotechnology is the focus of the industry in twenty-first Century, the broad market for the benefit of Shandong has provided a good opportunity.

Kong Qingbao said: "the company will make full use of the advantages of its own scientific research, rapid completion of the upgrading from the pharmaceutical intermediates to the finished product, to achieve the high technology output value to high technology and high value-added products, to achieve a diversified, operating mode of the group, the international business objectives." 3

(original title: Kong Qingbao: biotechnology is the focus of the industry in twenty-first Century)

Editor: small G